Gabrielle Masson

Talus Bio raises $11.2M seed+ to advance MARMOT platform and target hard-to-reach transcription factors in cancer

Talus Bio raised $11.2 million to advance preclinical cancer programs and expand its MARMOT discovery platform that uses AI, proteomics, synthetic chemistry, and computational biology to target difficult transcription factors driving cancers including prostate cancer and brachyury-driven chordoma.